Offer - Urjas Oil for just ₹ 1 X
Filnim is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Neutropenia.
The correct dosage of Filnim depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
While these are the most often observed Filnim side effects, there are can be others also. These have been listed below. These side effects of Filnim are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Filnim's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Filnim's effects on the liver, heart and kidney, if any, have been listed below.
Filnim is contraindicated in people with pre-existing medical conditions like Blood Cancer as it can result in adverse effects. Other conditions have been mentioned below in the Filnim contraindications section.
Besides this, Filnim may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Filnim is considered safe while driving, and is addictive.
Filnim is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Filnim safe for pregnant women?
Filnim may have some side effects during pregnancy. Pregnant women should discontinue the use of Filnim, and talk to their doctor, if they notice any discomfort.
Is the use of Filnim safe during breastfeeding?
Filnim can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Filnim on the Kidneys?
Filnim has very mild side effects on the kidneys.
What is the effect of Filnim on the Liver?
Very few cases of side effects of Filnim on the liver have been reported.
What is the effect of Filnim on the Heart?
Filnim may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Filnim should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Filnim unless your doctor advises you to do so -
Is this Filnim habit forming or addictive?
Forming a habit of Filnim has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Filnim does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Filnim should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Filnim is not used to treat mental disorders.
Interaction between Food and Filnim
There isn't any research available on the side effects of taking Filnim with food.
Interaction between Alcohol and Filnim
It is difficult to say anything about the effect of Filnim and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neupogen® (Filgrastim)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 567-560